共 50 条
- [25] Disseminated tuberculosis after Polatuzumab-Vedotin based chemoimmunotherapy in a patient with Burkitt's lymphoma CLINICAL CASE REPORTS, 2024, 12 (05):
- [27] Refractory hemophagocytic lymphohistiocytosis secondary to polatuzumab vedotin plus rituximab and bendamustine Annals of Hematology, 2024, 103 : 1017 - 1019